BREAKING NEWS
Coronavirus
Thailand Coronavirus News is a section dedicated to the new coronavirus that is causing an epidemic in China and fast spreading globally. The strain of coronavirus called Covid-19 or also commonly called the Wuhan coronavirus is genetically more potent and faster spreading than the SARS coronavirus. Currently teams are working to develop a new vaccine for this new coronavirus while other teams are...
Source: COVID-19 News  Sep 15, 2020  1 year ago
COVID-19 News: An international study lead by researchers from 25 institutions in Europe, America and Australia have found that smoking increases ACE2 receptors expression while inhaling corticosteroids has the opposite effect of suppressing the expression of these virus binding receptors.   The study findings in brief found that genes encoding viral receptors and activating protease are in...
Source: COVID-19 Second Wave Preparations  Sep 15, 2020  1 year ago
COVID-19 Second Wave Preparations: Researchers from John Hopkins University School of Medicine in a new study have found that it is useful for a pulse oximeter to be used at home to monitor COVID-19 patients.   The study was published on a preprint server and has yet to have been peer-reviewed. https://www.medrxiv.org/content/10.1101/2020.09.01.20184937v1   Accordingly a pulse oximeter...
Source: COVID-19 Drugs  Sep 14, 2020  1 year ago
COVID-19 Drugs: Researchers from the University of Pittsburgh School of Medicine claim to have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 coronavirus.   The research findings were published in the journal: Cell https://www.cell.com/cell/pdf/S0092-8674(20)31148-X.pdf?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%...
Source: Coronavirus Research  Sep 14, 2020  1 year ago
Coronavirus Research: Scientist from Yale University School Of Medicine, St. Jude Children's Research Hospital-Memphis, National Institutes of Health-Bethesda, Columbia University and  Montreal University-Canada using an imaging platform that utilizes single-molecule Förster resonance energy transfer (FRET) have discovered that the spike proteins of the SARS-CoV-2 coronavirus has 4 d...
Source: News-Coronavirus  Sep 14, 2020  1 year ago
WHO (World Health Organization) reported 307,930 new cases worldwide on Sunday, the highest daily figure in its database since the beginning of the pandemic.   The surge has sparked concern in Europe, where Austrian Chancellor Sebastian Kurz warned that his country was facing "the beginning of the second wave".   At the same time the Czech Republic has also faced a surge, wit...
Source: COVID-19 Vaccine  Sep 14, 2020  1 year ago
COVID-19 Vaccine : The AIDS Healthcare Foundation (AHF), the largest global AIDS organization, today (Monday,14th September)  sharply criticized pharmaceutical and biotech  companies working on COVID-19 vaccines over a near total lack of transparency on the companies’ respective trials, including setbacks with AstraZeneca’s vaccine trial that briefly forced its suspensio...
Source: Coronavirus News  Sep 14, 2020  1 year ago
Coronavirus News: Researchers from the Department of Hydrobiology at the Institute of DACBiol at the Universidad Juárez Autónoma de Tabasco-Mexico are warning that careful attention and monitoring needs to be paid to the aquatic life forms and water life as they could be potential impacts from the current COVID-19 pandemic. The researchers expressed their concerns and study findings...
Source: Vaccines-COVID-19  Sep 14, 2020  1 year ago
Vaccines-COVID-19: Indian researchers from vaccine developer Bharat Biotech International Ltd in collaboration with researchers National Institute of Virology-Indian Council of Medical Research have conducted a preclinical study demonstrating the safety and efficacy of a new candidate vaccine against the SARS-CoV-2 coronavirus, the pathogen that causes the COVID-19 disease.   The ...
Source: COVID-19 Mask  Sep 14, 2020  1 year ago
COVID-19 Mask: A study and development team from the City University of Hong Kong (CityU) has successfully produced graphene masks with an anti-bacterial efficiency of 80%, which can be enhanced to almost 100% with exposure to sunlight for around 10 minutes. Initial tests also showed very promising results in the deactivation of two species of coronaviruses. The graphene masks are easily...
Source: Latest COVID-19  Sep 13, 2020  1 year ago
Latest COVID-19 studies by researchers from the Regenerative Neurorehabilitation Laboratory (The Shirley Ryan AbilityLab) at Northwestern University Feinberg School of Medicine- Chicago have shown that proning (the technique of placing a patient in a face down position to ease breathing and reduce mortality rates) of severely ill COVID-19 patients on ventilators can cause permanent nerve...
Source: U.S. Coronavirus News  Sep 13, 2020  1 year ago
U.S. Coronavirus News: The U.S. Centers for Disease Control and Prevention said that there have been 792 confirmed cases of a rare condition in children that is linked to COVID-19 in the United States and warns that there are lots more of suspected cases being investigated and that these figures are rising.   The U.S. CDC  added that multisystem inflammatory syndrome in children (MIS-C...
Source:ACE-i And ARBs-COVID-19   Sep 13, 2020  1 year ago
ACE-i And ARBs-COVID-19: According to latest research findings presented at the virtual American Heart Association’s Hypertension 2020 Scientific Sessions that was held Sept. 10-13, 2020, reducing or eliminating high blood pressure medications if blood pressure becomes hypotensive, falling below 120/70 mm Hg, could prevent acute kidney injury (AKI) and death in COVID-19 patients. ...
Source: COVID-19 Breakthrough  Sep 13, 2020  1 year ago
COVID-19 Breakthrough: Clinical-stage biopharmaceutical company Senhwa Biosciences that is based in Taiwan with offices in San Diego has announced that its investigational drug, Silmitasertib has demonstrated remarkable effectiveness after the first patient with severe COVID-19 demonstrated remarkable recovery after using the drug. Senhwa Biosciences is a company focused on next generation DNA Da...
Source: Coronavirus News  Sep 13, 2020  1 year ago
Coronavirus News: There are unproven speculations by medical experts and scientific researchers circulating around about a particular South-East Asian country where it is estimated that about 4% of its population of locals might have already contracted the ‘milder’ strains of the SARS-CoV-2 coronavirus but almost 96 percent of these infected locals are asymptomatic while the rest might...
Source: Vaccines-COVID-19  Sep 13, 2020  1 year ago
Vaccines-COVID-19: The world’s oral recombinant adenoviral mucosal COVID-19 vaccine by Vaxart, Inc, a California based biotechnology company that is administered by tablet rather than by injection, has demonstrated positive results in a inducing potent systemic and mucosal immune responses in preclinical studies.   The study findings were published on a preprint server and are current...
Source: COVID-19 Treatments  Sep 12, 2020  1 year ago
COVID-19 Treatments: Researchers from Mississippi have in a new study found that utilizing both the antihistamines Cetirizine and Famotidine appears to reduce pulmonary symptoms and may have other benefits in patients with COVID-19. The study findings were published in the journal:  Pulmonary Pharmacology & Therapeutics https://www.sciencedirect.com/science/article/pii/S1094553920301462?...
Source: Coronavirus News  Sep 12, 2020  1 year ago
Coronavirus News: As most people once again go out freely this weekend in denial of what is coming and how they are indirectly contributing to it, the official global COVID-19 deaths has now reached 916,125 while the official numbers of those infected have now reached more than 28.5 million. As we all know by the now the reality is that the actual numbers are much higher than this and it is going ...
Source: Influenza 2020/2021  Sep 12, 2020  1 year ago
Influenza 2020/2021: Researchers from the Perelman School of Medicine- University of Pennsylvania have found that middle-aged individuals ie those born in the late 1960s and the 1970s may be in a perpetual state of H3N2 influenza virus susceptibility because their antibodies bind to H3N2 viruses but fail to prevent infections.   The study findings were published in the journal: Nature Commu...
Source: COVID-19-Livestock  Sep 12, 2020  1 year ago
COVID-19-Livestock: A new study by the Canadian Food Inspection Agency-Manitoba involving researchers from University of Manitoba and also from the Iowa State University-U.S. has found that pigs are also susceptible to the SARS-CoV-2 coronavirus. The study results could have a magnitude effects on the livestock industry and also has implications on zoonotic transmissions and potential induced muta...
Source: T Cells-COVID-19  Sep 11, 2020  1 year ago
T Cells-Covid-19: Australian researchers from University of Melbourne, Monash University, La Trobe University, James Cook University and University of Tasmania have discovered that killer T cells, key immune cells in fighting viral infections, are present at much lower levels in individuals with COVID-19, compared to influenza or glandular fever.   As CD8+ T cell memory promotes rapid ...
Source: Herbs-COVID-19  Sep 11, 2020  1 year ago
Herbs-COVID-19: While the Western (America, Europe, Australia and Canada) world that loves to typically denounce herbal therapies are getting infected and dying by the droves and pinning their hopes on overpriced toxic drugs churned out by their greedy pharmaceutical companies and aided by their corrupted governments and further supported by their ‘bastard’ media and social media platf...
Source: Myanmar COVID-19 News  Sep 11, 2020  1 year ago
Myanmar COVID-19 News: Authorities in Myanmar on Friday announced its toughest measures so far to control the spread of the coronavirus, banning travel out of the country's biggest city, Yangon, and grounding all domestic flights. The city is experiencing a huge surge cases and hospital are overflowing with test kits being scarce.   Travel in and out of the city by other transport syste...
Source: Antibodies COVID-19  Sep 11, 2020  1 year ago
Antibodies COVID-19: Another study by researchers from Nanjing University Medical School -China led by Dr Chao Wu and Dr Rui Huang, both infectious disease and immunology specialists show that various factors contribute to the fact that antibodies might not be a good solution to treat COVID-19 coupled with the fact that most convalescent treatments did not produce positive results due to lack of t...
Source: COVID-19 Immunology  Sep 11, 2020  1 year ago
COVID-19 Immunology: According to Professor Dr Marc Hellerstein of the University of California-Berkeley, althought more than 120 companies have rushed into vaccine development against COVID-19 as the U.S. government pushes for a vaccine rollout at "warp speed"-possibly by the end of the 2020,  the bar set for an effective, long-lasting vaccine is far too low and may prove dangerous...
Source: COVID-19 Research  Sep 11, 2020  1 year ago
COVID-19 Research: A new study by researchers from Indiana University-U.S. led by Professor Dr Nir Menachemi from the university’s School of Public Health has found that the COVID-19 disease caused by the SARS-CoV-2 coronavirus is hundreds of times more deadly for individuals over 60 compared to those under 40.   The study findings were published in the journal: Annals Of Internal Med...
Source: COVID-19 Warnings  Sep 10, 2020  1 year ago
COVID-19 Warnings: Researchers from Huazhong Agricultural University-China  led By Dr Meilin Jin, a Professor from the Department of Agricultural Microbiology have in a new study that was based in Wuhan have discovered that more cats might be contracting the SARS-CoV-2 coronavirus  than first believed.   The study also shows that cats are fighting off the virus with naturally deve...
Source: COVID-19 World News  Sep 10, 2020  1 year ago
COVID-19 World News: The world is now seeing daily infection rates of average above 240,000 new infections per day for the last 2 months with the record highest that was on the 4th of September with almost 300,683 reported cases. As of today the total number of infections has reached almost 28 million with global COVID-19 deaths amounting to about 904,124. Forget about the recovery rates as we now...
Source: COVID-19 News  Sep 10, 2020  1 year ago
COVID-19 News: British researchers led by the University of Cambridge, Addenbrooke's Hospital, Cambridge University NHS Foundation Trust and  various British hospitals and medical universities have found that as many as one in 100 patients admitted to hospital with COVID-19 will eventually develop a condition known as pneumothorax or  'punctured lung'. The condition was also ...
Source: COVID-19 Convalescent Plasma  Sep 10, 2020  1 year ago
COVID-19 Convalescent Plasma: An open-label, parallel-arm, phase II, multicentre, randomized controlled trial (PLACID) in India has shown that the use of convalescent plasma as a therapeutic for moderate COVID-19 patients showed no positive effects and did not improve the outcome of the patients.   The study findings are published on a preprint server and are currently being peer reviewed. ...
Source: COVID-19 Latest  Sep 10, 2020  1 year ago
COVID-19 Latest: Researchers from Icahn School of Medicine-Mount Sinai are warning the manifestation of AKI or acute kidney injury is on the exponential rise in hospitalized COVID-19 patients and a high proportion are dying as a result or will never recover from it even after being discharged.   The research findings are published in Journal of the American Society of Nephrology. https://ja...
Source: COVID-19 Research  Sep 10, 2020  1 year ago
A new COVID-19 Research by scientist from Murdoch University-Australia led by Professor Dr Jeremy K. Nicholson and Professor Dr Elaine Holmes have discovered that by comparing lipoproteins and metabolites in the blood of COVID-19 patients and healthy subjects, not only are signs of multi-organ damage apparent but a distinct metabolite signature was observed in COVID-19 patients that could be furth...
Source: Multisystem Inflammatory Syndrome or MIS-C  Sep 09, 2020  1 year ago
Multisystem Inflammatory Syndrome or MIS-C could be triggered by high antiviral antibody levels in COVID-19 Infected Children according to researchers from at Emory University School of Medicine and Children's Healthcare of Atlanta.   The study team said that measuring blood antibody levels against SARS-CoV-2 may distinguish children with multisystem inflammatory syndrome (MIS-C), ...
Source: Anxiety and Stress  Sep 09, 2020  1 year ago
Anxiety and Stress: Researchers from Washington State University have found in a new study that exercise which typically helps by reducing anxiety and stress is unable to help with COVID-19 related mental issues.   Surprisingly in a study of twins led by the study team, individuals who reported increasing their physical activity after the start of COVID-19 stay-at-home orders reported highe...
Source: COVID-19 Alerts  Sep 09, 2020  1 year ago
COVID-19 Alerts: According to a new UK study by Universities of Warwick and Birmingham, home-testing kits sold online in the UK, US and elsewhere in the midst of the COVID-19 crisis were provided with incomplete and in most cases, misleading information on how accurate they were.   Worst till there were reports from other regulatory bodies, medical institutions and consumer boards that some...
Source: COVID-19 Immunity  Sep 09, 2020  1 year ago
COVID-19 Immunity is short-lived for those who had mild symptoms when they were first infected with the SARS-CoV-2 coronavirus or were asymptomatic according to a new study by Chinese researchers from the Army Medical University in Chongqing led by Dr Ye Lilin, a leading Immunologist from the University’s Institute of Immunology.   The study also indicates that the absence of the key ...
Source:   Sep 09, 2020  1 year ago
Vaccine-COVID-19: It was announced the last few hours that the large phase 3 clinical trial of the COVID-19 vaccine AZD1222 developed by the University of Oxford and Astrazenaca was stopped in the last 24 hours and put on hold as a result of reported serious adverse reactions.   The sudden stoppage affected numerous testing sites globally especially in the United States and United Kingdom a...
Source: Drugs And COVID-19  Sep 09, 2020  1 year ago
Drugs And COVID-19: Danish researchers led by Dr Anton Pottegård of the University of Southern Denmark along with other scientists from Aarhus University Hospital and the Danish Medicines Agency have in a new study found that the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and diclofenac, is not associated with any adverse effects in people who have tested p...
Source: COVID-19 News  Sep 09, 2020  1 year ago
COVID-19 News: Researchers from Massachusetts General Hospital (MGH)-U.S. have in a new study shown that the blood clotting protein factor V plays a very critical role in the outcomes of hospitalized COVID-19 patients.   Factor V (pronounced factor five) is a protein of the coagulation system, sometimes referred to as proaccelerin or labile factor. In contrast to most other coagul...
Source: COVID-19 Second Wave  Sep 08, 2020  1 year ago
COVID-19 Second Wave: Before anyone accuse us of fear mongering, first look at some simple facts…..when the COVID-19 pandemic first broke out, it started with a couple of hundred infected individuals that caused the virus to spread worldwide. Today despite border controls or closures, we have millions of people worldwide who are infected and millions more in our midst that are asymptomatic....
Source: COVID-19 Gut  Sep 08, 2020  1 year ago
COVID-19-Gut: A new study by researchers from the Chinese University of Hong Kong has found that the SARS-CoV-2 coronavirus may continue to infect and replicate in the digestive tract after clearing in the airways. https://www.cpr.cuhk.edu.hk/en/press_detail.php?id=3356   It was also observed that COVID-19 patients have active and prolonged gut viral infection, even in the absence of gastro...
Source: Diagnostics-COVID-19  Sep 08, 2020  1 year ago
Diagnostics-COVID-19: UK based biotech firm Avacta Group plc ,the developer of Affimer® biotherapeutics and reagents has announced the launch of an ultra-sensitive ELISA laboratory test for the SARS-CoV-2 spike protein to support global research efforts into the SARS-CoV-2 coronavirus that causes COVID-19. Dr Alastair Smith, Avacta’s chief executive   ELISAS or enzyme l...
Source: Drugs-COVID-19  Sep 08, 2020  1 year ago
Drugs-COVID-19: Researchers from Memorial Sloan Kettering Cancer Center-New York in a new study suggest that using drugs such as PI3K/mTOR And Topoisomerase inhibitors reduces ACE2 expression and reduces risk and an individual’s susceptibility to the SARS-CoV-2 coronavirus that causes the COVID-19 disease.   As ACE2 are the main and first receptors that the SARS-CoV-2 coronavirus uses...
Source: COVID-19 Diagnostics  Sep 08, 2020  1 year ago
COVID-19 Diagnostics: Researchers from Icahn School of Medicine-Mount Sinai in a new study have found that D-Dimers, a fragment protein produced by the breakup of fibrin clots can be used as a biomarker to determine which patients are at the risk of dying.   Information such as this which predicts a COVID-19 patient’s risk of mortality is useful in designing clinical treatment protoco...
Source: Influenza Vaccinations And COVID-19  Sep 07, 2020  1 year ago
Influenza Vaccinations And COVID-19: A new study by Canadian researchers from Laval University and McGill University show that live attenuated influenza vaccine (LAIV) can offer a certain degree of protection against the COVID-19 disease  compared to inactivated influenza vaccines (IIV) containing three or four variants. The study findings also suggest that inactivated influenza vaccines II...
Source: SARS-CoV-2 Transmission Via Frozen Food  Sep 07, 2020  1 year ago
SARS-CoV-2 Transmission Via Frozen Food: A new research by Chinese researchers from the South China Agricultural University-Guangzhou, Institute of Animal Health-Guangdong and Fudan University-Shanghai has confirmed that the SARS-CoV-2 coronavirus is able to survive on seafood such as salmon for up to 8 days at 4 degrees Celsius which is the temperature of most frozen storage facilities for seafoo...
Source: COVID-19 Next Generation Vaccines  Sep 07, 2020  1 year ago
COVID-19 Next Generation Vaccines: Cambridge based Elicio Therapeutics has developed a next generation COVID-19 vaccine ELI-005 that is expected to start initial clinical trials soon. Unlike most of the current genetic based vaccines under development or in phase 3 trials, this lymph node-targeting vaccine is composed of an adjuvant developed using the company’s Amphiphile technology and the...
Source: India COVID-19-Coronavirus News  Sep 07, 2020  1 year ago
India COVID-19-Coronavirus News: India reported its fourth documented case of COVID-19 reinfection in the IT city Bengaluru on Sunday. Someone Should Really Show Him How To Wear A Mask Correctly   The patient, a female aged 27 years from the southern Indian city who got recovered from an initial infection from SARS-CoV-2 in July, has tested positive again for the virus. The confirmation of ...
Source: United Kingdom And Israel COVID-19 News  Sep 07, 2020  1 year ago
United Kingdom reported almost 3,000 new coronavirus cases over 24 hours, a level not seen since late May according to health authorities on Sunday.   Also it was reported that two more people had died after testing positive over the past 28 days, bringing Britain’s overall death toll to 41,551, Europe's highest.   Also, 2,990 new cases were recorded, significantly higher tha...
Source: Herbs For COVID-19  Sep 07, 2020  1 year ago
Herbs For COVID-19: A number of studies are now emerging showing that the phytochemical Tryptanthrin extracted from the leaves of the Strobilanthes Cusia plant also known as Assam Indigo or Chinese Rain Bell has potential efficacy as an antiviral against the SARS-CoV-2 coronavirus which causes the deadly COVID-19 disease.   Scientifically known as Strobilanthes Cusia, the plant blooms ...
Source: COVID-19 Research  Sep 06, 2020  1 year ago
COVID-19 research by German scientists from the University of Tuebingen shows that the SARS-CoV-2 coronavirus basically paralyzes the cytotoxic and metabolic functions of the human host immune cells which leads to disease severity and progression.   The study findings are published on a preprint server and are currently being peer-reviewed. https://www.biorxiv.org/content/10.1101/2020.09.04...
Source: Australia COVID-19  Sep 06, 2020  1 year ago
The COVID-19 lockdown in the Australian second-biggest city of Melbourne has been extended by another two weeks according to government and health officials who said that new cases had not dropped enough to prevent another surge. An Australian Protester In Melbourne.   Australians in Melbourne were due to exit a harsh six-week lockdown next weekend but face continued restrictions for months...
Source: Thailand COVID-19 News  Sep 06, 2020  1 year ago
Thailand COVID-19 News:  6 new COVID-19 cases were reported in Thailand today (Sunday, 6th September) of which three could be COVID-19 reinfections! Westerners Not Wearing Mask Still A Common Sight In Thailand   The CCSA or Centre for Covid-19 Situation Administration Thailand said that of the 6 cases, 3 were Thai male nationals who had been previously infected in Singapore but had sin...
Source: COVID-19 Antibody  Sep 06, 2020  1 year ago
COVID-19 antibody immunity and virus neutralizing capabilities will be critical to control the anticipated worsening of the SARS-CoV-2 pandemic however already emerging studies are indicating that there could be many complications and disappointments although numerous pharmaceutical and biotech companies along with certain governments are trying to conceal these news in order to either profit from...
Source: America COVID-19 News  Sep 06, 2020  1 year ago
America COVID-19 News: COVID-19 cases are rising in the various campuses of U.S. colleges and universities, leading authorities to react in a vast array of ways including reverting back to classes going online and a sudden rise of disciplinary actions and dismissals as school authorities try to maintain control in the campuses.   It was found that most of the students breaking social distan...
Source: Narsoplimab And COVID-19  Sep 06, 2020  1 year ago
Narsoplimab And COVID-19: Researchers are now saying that treatments for COVID-19 may be focusing on at the wrong elements of the disease based on emerging data from Bergamo, Italy, the epicenter of the pandemic in Europe.   Italian researchers realized, as they combed through the data, that COVID-19 is an endothelia injury rather than a pulmonary event and that stopping the complement casc...

MOST READ

Feb 05, 2020  2 years ago
Source : Thailand Medical news

Interesting Reads

Source: COVID-19 Convalescent Plasma and Hyperimmune Plasma Or H-Ig Therapies
Jun 15, 2020  1 year ago
Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020  1 year ago
Source: COVID-19 Long-Term Health Implications
Jun 13, 2020  1 year ago
Source: COVID-19, Influenza and Next Wave
Jun 10, 2020  1 year ago
Source: Myocardial Injury
Jun 09, 2020  1 year ago
Source: COVID-19 News
May 21, 2020  1 year ago
Source: Covid-19 Treatments And Drugs News
Mar 20, 2020  2 years ago
Source: SARS-Cov-2 Coronavirus Research
Mar 08, 2020  2 years ago
Source : Thailand Medical News
Feb 11, 2020  2 years ago